医学
贫血
转铁蛋白饱和度
红细胞生成
血液透析
血红蛋白
协议(科学)
目标射程
内科学
重症监护医学
缺铁
替代医学
宏观经济学
病理
经济
作者
Lina María Castaño‐Jaramillo,Audra Bos,Jessica VanSetters,L Czarnecki,Yi Cai,Alejandro Quiroga Chand
标识
DOI:10.37526/1526-744x.2020.47.3.253
摘要
A high proportion of patients on hemodialysis persist with low hemoglobin levels despite receiving treatment with erythropoiesis-stimulating agents. A registered nurse-driven renal anemia protocol was designed and implemented by a team in a pediatric hemodialysis unit. We compared proportion of patients achieving the target hemoglobin (Hgb) and transferrin saturation (TSAT) before and after the implementation of the protocol. There was an increase in patients achieving the target Hgb and TSAT range, with an increase in the Hgb concentration. There were no differences in the proportion of patients with left ventricular hypertrophy, erythropoiesis-stimulating agents or intravenous iron dose, transfusion rates, or hospitalization rates. The implementation of a nurse-driven anemia protocol in a pediatric hemodialysis unit increased the proportion of patients achieving target Hgb and TSAT range without a rise in medication doses.
科研通智能强力驱动
Strongly Powered by AbleSci AI